November 20, 2025

Blog

New Performance Data Shows Why Pharma Is Reallocating Spend Toward Direct-to-Patient Care

New Performance Data Shows Why Pharma Is Reallocating Spend Toward Direct-to-Patient Care Pharmaceutical brands are increasingly shifting investment toward direct-to-patient

Services

The Fragmented Middle

Connection to care is the new bar in direct-to-patient

From Awareness to Care Progression: Why the Funnel Isn’t Fixed at the First Click

Moving Pharmacy Upstream: The Strength of Earlier Pharmacy Integration

New Performance Data Shows Why Pharma Is Reallocating Spend Toward Direct-to-Patient Care

Fierce Pharma Highlights Pharma’s Shift Toward Direct-to-Patient Models

ixlayer and Ipsos’ “ixInsights 2025” Study Reveals Consumer Expectations for Digital Health and Pharma’s Role in Enhancing Patient Experience

MediaPost Highlights Need to Move From Awareness to Action

Fierce Pharma Week 2025 Interview